Search

everythinglearnresearchcommunity

for

Search:↓

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Both finasteride and metformin effectively treat PCOS by reducing hormone levels and insulin resistance.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Oxidative stress is higher in women with PCOS, especially if they're obese, and it may increase their risk of heart disease.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Young women with PCOS and no other heart risk factors have normal heart function.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Hair loss in young men linked to higher risk of insulin resistance and metabolic issues.

Finasteride and metformin both help treat PCOS, but using them together works best.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Women with PCOS have more insulin resistance and are more likely to have heart-related health issues, with insulin resistance being a bigger factor than β-cell problems.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Family members of North Indian women with PCOS have a high rate of metabolic syndrome.